Eli Lilly disclosed in an SEC filing that Nobel laureate Carolyn Bertozzi will rejoin its board on Dec. 8. Bertozzi, who won the 2022 Nobel Prize in Chemistry for bioorthogonal chemistry, brings deep expertise in glycobiology and translational research. Her appointment signals Lilly’s continued emphasis on cutting-edge biologics and chemical biology as the company advances oncology and protein-based therapeutic programs.